Price:
Rs. 6,530.00
Sample Type: EDTA Blood
Fasting Not Required
Notes: D0054
Frequently Asked Questions (FAQ's):
What does the DRPLA Gene Analysis test include?
This test screens for mutations or repeat expansions in the DRPLA gene that cause Dentatorubral-Pallidoluysian Atrophy.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated molecular techniques, including PCR and sequencing, to detect DRPLA gene mutations accurately.
Who should take this test?
Patients with symptoms such as movement disorders, seizures, or cognitive decline suggestive of DRPLA, and individuals with a family history of the disorder, may be advised to take this test.
What sample type is required?
A blood sample, usually collected in EDTA tubes, is required to extract high-quality DNA for analysis.
Why is DRPLA gene testing important?
Detecting mutations helps confirm diagnosis, guide treatment and management, and provide information for genetic counseling and family planning.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows strict quality control, validated molecular protocols, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No special preparation or fasting is required; patients should follow physician instructions for sample collection.
How soon are results available?
Turnaround time may vary depending on test complexity, but Metropolis Healthcare provides timely reports to support clinical and genetic decision-making.